©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2013; 19(22): 3439-3446
Published online Jun 14, 2013. doi: 10.3748/wjg.v19.i22.3439
Published online Jun 14, 2013. doi: 10.3748/wjg.v19.i22.3439
Table 1 Sedation regimens
| Midazolam-fentanyl | |
| Midazolam | |
| Initial dose | |
| ASA I | 3-5 mg |
| ASA II or III | 2-3 mg |
| Maintenance | 0.5-1.0 mg every 2-3 min, up to a maximum cumulative dose of 10 mg or 0.1 mg/kg of body weight |
| Fentanyl | |
| Single dose | |
| ASA I | 50 μg |
| ASA II or III | 20-30 μg |
| Propofol-fentanyl | |
| Propofol | |
| Initial dose | |
| ASA I | 0.5 mg/kg |
| ASA II or III | 0.25 mg/kg |
| Maintenance | 10-20 mg bolus at 60 s intervals |
| Fentanyl | |
| Single dose | |
| ASA I | 50 μg |
| ASA II or III | 20-30 μg |
- Citation: Santos MELD, Maluf-Filho F, Chaves DM, Matuguma SE, Ide E, Luz GO, Souza TF, Pessorrusso FCS, Moura EGH, Sakai P. Deep sedation during gastrointestinal endoscopy: Propofol-fentanyl and midazolam-fentanyl regimens. World J Gastroenterol 2013; 19(22): 3439-3446
- URL: https://www.wjgnet.com/1007-9327/full/v19/i22/3439.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i22.3439